Koers M Pharmaceutical Inc Deutsche Boerse AG
Aandelen
CA55346E2050
Biotechnologie & Medisch Onderzoek
Omzet 2018 | 0,75 0,69 | Omzet 2019 | 0,71 0,65 | Marktkapitalisatie | 3,53 mln. 3,24 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -5 mln. -4,6 mln. | Nettowinst (verlies) 2019 | -1 mln. -920K | EV/omzet 2018 | 4.852.616 x |
Nettoschuld 2018 | 319K 293K | Nettoschuld 2019 | 848K 780K | EV/omzet 2019 | 6.168.166 x |
K/w-verhouding 2018 |
-0,6
x | K/w-verhouding 2019 |
-1,97
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 72,04% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 03-01-18 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 01-12-14 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,77% | 49,46 mld. | |
+1,00% | 42,58 mld. | |
+49,90% | 42,49 mld. | |
-5,26% | 29,09 mld. | |
+13,68% | 26,61 mld. | |
-22,99% | 18,64 mld. | |
+8,22% | 13,16 mld. | |
+32,41% | 12,55 mld. | |
+24,01% | 12,1 mld. |